Parkside Financial Bank & Trust’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $394K | Hold |
884
| – | – | 0.04% | 288 |
|
2025
Q1 | $429K | Buy |
884
+17
| +2% | +$8.24K | 0.05% | 240 |
|
2024
Q4 | $349K | Sell |
867
-40
| -4% | -$16.1K | 0.05% | 261 |
|
2024
Q3 | $422K | Buy |
907
+8
| +0.9% | +$3.72K | 0.06% | 225 |
|
2024
Q2 | $421K | Buy |
899
+16
| +2% | +$7.5K | 0.07% | 215 |
|
2024
Q1 | $369K | Buy |
883
+76
| +9% | +$31.8K | 0.06% | 238 |
|
2023
Q4 | $328K | Buy |
807
+162
| +25% | +$65.9K | 0.06% | 238 |
|
2023
Q3 | $224K | Buy |
645
+50
| +8% | +$17.4K | 0.05% | 242 |
|
2023
Q2 | $209K | Buy |
595
+134
| +29% | +$47.2K | 0.05% | 252 |
|
2023
Q1 | $145K | Buy |
461
+33
| +8% | +$10.4K | 0.04% | 296 |
|
2022
Q4 | $124K | Buy |
428
+13
| +3% | +$3.75K | 0.04% | 326 |
|
2022
Q3 | $120K | Buy |
415
+7
| +2% | +$2.02K | 0.04% | 298 |
|
2022
Q2 | $115K | Buy |
408
+26
| +7% | +$7.33K | 0.04% | 304 |
|
2022
Q1 | $99K | Buy |
382
+30
| +9% | +$7.78K | 0.03% | 365 |
|
2021
Q4 | $77K | Buy |
352
+28
| +9% | +$6.13K | 0.02% | 418 |
|
2021
Q3 | $58K | Buy |
324
+7
| +2% | +$1.25K | 0.02% | 466 |
|
2021
Q2 | $64K | Buy |
317
+21
| +7% | +$4.24K | 0.02% | 442 |
|
2021
Q1 | $63K | Sell |
296
-9
| -3% | -$1.92K | 0.02% | 420 |
|
2020
Q4 | $72K | Sell |
305
-19
| -6% | -$4.49K | 0.02% | 369 |
|
2020
Q3 | $88K | Sell |
324
-3
| -0.9% | -$815 | 0.03% | 316 |
|
2020
Q2 | $95K | Sell |
327
-50
| -13% | -$14.5K | 0.03% | 314 |
|
2020
Q1 | $90K | Buy |
377
+26
| +7% | +$6.21K | 0.03% | 275 |
|
2019
Q4 | $77K | Buy |
351
+33
| +10% | +$7.24K | 0.02% | 343 |
|
2019
Q3 | $54K | Buy |
318
+9
| +3% | +$1.53K | 0.02% | 397 |
|
2019
Q2 | $57K | Buy |
309
+11
| +4% | +$2.03K | 0.02% | 375 |
|
2019
Q1 | $55K | Sell |
298
-25
| -8% | -$4.61K | 0.02% | 365 |
|
2018
Q4 | $54K | Buy |
323
+48
| +17% | +$8.03K | 0.02% | 341 |
|
2018
Q3 | $53K | Hold |
275
| – | – | 0.02% | 357 |
|
2018
Q2 | $47K | Sell |
275
-81
| -23% | -$13.8K | 0.02% | 371 |
|
2018
Q1 | $58K | Buy |
356
+7
| +2% | +$1.14K | 0.02% | 318 |
|
2017
Q4 | $52K | Sell |
349
-11
| -3% | -$1.64K | 0.02% | 353 |
|
2017
Q3 | $55K | Buy |
360
+34
| +10% | +$5.19K | 0.02% | 327 |
|
2017
Q2 | $42K | Buy |
326
+126
| +63% | +$16.2K | 0.02% | 372 |
|
2017
Q1 | $22K | Buy |
200
+10
| +5% | +$1.1K | 0.01% | 511 |
|
2016
Q4 | $14K | Sell |
190
-14
| -7% | -$1.03K | 0.01% | 618 |
|
2016
Q3 | $18K | Buy |
204
+8
| +4% | +$706 | 0.01% | 593 |
|
2016
Q2 | $17K | Sell |
196
-60
| -23% | -$5.2K | 0.01% | 580 |
|
2016
Q1 | $20K | Buy |
256
+19
| +8% | +$1.48K | 0.01% | 523 |
|
2015
Q4 | $30K | Sell |
237
-63
| -21% | -$7.98K | 0.01% | 428 |
|
2015
Q3 | $31K | Buy |
+300
| New | +$31K | 0.02% | 392 |
|